<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life-science briefing: Tuesday, March 11, 2008</title>
	<atom:link href="http://venturebeat.com/2008/03/11/life-science-briefing-tuesday-march-11-2008/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2008/03/11/life-science-briefing-tuesday-march-11-2008/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Mon, 23 Nov 2009 13:10:15 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Life-science briefing: Wednesday, March 19, 2008 &#187; VentureBeat</title>
		<link>http://venturebeat.com/2008/03/11/life-science-briefing-tuesday-march-11-2008/comment-page-1/#comment-799593</link>
		<dc:creator>Life-science briefing: Wednesday, March 19, 2008 &#187; VentureBeat</dc:creator>
		<pubDate>Thu, 20 Mar 2008 16:22:35 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/03/11/life-science-briefing-tuesday-march-11-2008/#comment-799593</guid>
		<description>[...] VeraCyte (no Web site), VentureWire reports. The new name presumably reflects the company&#8217;s focus on cell-based cancer diagnostics, as we described last [...]</description>
		<content:encoded><![CDATA[<p>[...] VeraCyte (no Web site), VentureWire reports. The new name presumably reflects the company&#8217;s focus on cell-based cancer diagnostics, as we described last [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Calderome takes in $12M for cancer diagnostics &#187; VentureBeat</title>
		<link>http://venturebeat.com/2008/03/11/life-science-briefing-tuesday-march-11-2008/comment-page-1/#comment-798555</link>
		<dc:creator>Calderome takes in $12M for cancer diagnostics &#187; VentureBeat</dc:creator>
		<pubDate>Wed, 12 Mar 2008 16:51:02 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/03/11/life-science-briefing-tuesday-march-11-2008/#comment-798555</guid>
		<description>[...] our story about this South San Francisco, Calif., cellular-diagnostics startup in Tuesday&#8217;s daily briefing at VentureBeat LifeScience.    SHARETHIS.addEntry({ title: &quot;Calderome takes in $12M for cancer [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this South San Francisco, Calif., cellular-diagnostics startup in Tuesday&#8217;s daily briefing at VentureBeat LifeScience.    SHARETHIS.addEntry({ title: &#8220;Calderome takes in $12M for cancer [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
